Rapid weight loss on popular drugs could ‘starve’ the brain, expert warns
Popular weight loss drugs may have unintended side effects.
25 independently detected trends connected to this subject, with the latest coverage first.
This hub groups 25 separate news trends connected to Mounjaro, spanning June 25, 2026 through October 2, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 207 article observations and 196 source signals, led by Health, Business, Entertainment coverage. Use it to compare how individual events emerged, spread and changed over time.
Popular weight loss drugs may have unintended side effects.
A new study hints Zepbound could ignite calorie‑burning brown fat, sparking hope and doubt in the obesity‑drug market.
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
13 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
4 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Popular GLP-1 drugs linked to life-threatening brain disorder and suicidal thoughts after weight regain.
GLP-1 weight-loss drugs could cut sleep-apnea rates, opening a new market and clinical pathway for millions.
Ozempic may boost mental health, sparking debate over GLP‑1 drugs' psychological impact
GLP-1 medications may worsen or speed hair loss in some men, study finds.
A surge in GLP‑1 prescriptions turns personal weight‑loss choices into a public debate demanding explanations.
Low‑dose GLP‑1 therapies may unlock weight loss with less drug, reshaping treatment standards
11 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
The FDA's approval of a new use for the diabetes drug Mounjaro is trending, with five outlets reporting on the expanded indication.
The FDA's approval of Lilly's Mounjaro for cardiovascular risk reduction is a major win for the company and a potential game-changer for diabetes patients.
New research has linked a popular GLP medication to increased hair loss, sparking discussions among health experts.
Recent reports indicate that users of GLP-1 receptor agonists are experiencing significant hair loss, sparking medical interest in these medications.
A popular diabetes drug may also protect against heart attacks, but the mechanism is still unclear.
A 19-year-old law student has died following the use of the weight loss drug Tirzepatide, prompting an official coroner's inquest.
Nearly 200 deaths in the UK have been linked to popular weight-loss drugs Ozempic and Mounjaro, raising urgent questions about their safety.
Eli Lilly's stock surges as demand for its weight-loss drugs continues to drive revenue growth.
A side effect of popular weight-loss drugs is causing patients to appear older.
Amy Schumer's unfiltered bikini photos from a yacht trip are trending, sparking conversations about body image and weight loss.
Health regulators and legal firms are responding to a linked risk of rare blindness and eye disorders associated with GLP-1 weight-loss medications.
14 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Ozempic users report unexpected changes in their sense of smell and taste.